Avricore Health Inc. (TSXV:AVCR)
0.0600
+0.0100 (20.00%)
May 16, 2025, 3:59 PM EDT
Avricore Health Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -0.67 | -0.7 | -0.82 | -1.71 | -1.17 | Upgrade
|
Depreciation & Amortization | 0.45 | 0.41 | 0.18 | 0.02 | - | Upgrade
|
Other Amortization | - | 0.01 | 0.01 | - | - | Upgrade
|
Loss (Gain) From Sale of Assets | 0.03 | - | - | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | 0.77 | - | - | - | - | Upgrade
|
Stock-Based Compensation | 0.54 | 0.7 | 0.33 | 0.5 | 0.13 | Upgrade
|
Provision & Write-off of Bad Debts | - | 0 | 0.01 | - | - | Upgrade
|
Other Operating Activities | -0.01 | - | - | 0.04 | 0.29 | Upgrade
|
Change in Accounts Receivable | 0.01 | 0.34 | -0.69 | -0.08 | 0 | Upgrade
|
Change in Inventory | 0.02 | -0.02 | - | - | -0.18 | Upgrade
|
Change in Accounts Payable | -0.16 | 0.18 | 0.27 | -0.07 | -0.34 | Upgrade
|
Change in Unearned Revenue | - | -0.25 | 0.25 | - | - | Upgrade
|
Change in Other Net Operating Assets | 0.02 | -0.01 | 0.02 | 0.07 | 0.05 | Upgrade
|
Operating Cash Flow | 1 | 0.66 | -0.44 | -1.23 | -1.22 | Upgrade
|
Operating Cash Flow Growth | 52.12% | - | - | - | - | Upgrade
|
Capital Expenditures | -0.18 | -1.02 | -1.19 | -0.11 | - | Upgrade
|
Sale (Purchase) of Intangibles | -0.02 | -0.03 | -0.01 | -0.04 | - | Upgrade
|
Investment in Securities | - | - | -0.01 | - | - | Upgrade
|
Investing Cash Flow | -0.21 | -1.05 | -1.21 | -0.14 | - | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 0.94 | Upgrade
|
Total Debt Issued | - | - | - | - | 0.94 | Upgrade
|
Short-Term Debt Repaid | -0.03 | - | - | -1 | - | Upgrade
|
Long-Term Debt Repaid | - | - | - | - | -0.01 | Upgrade
|
Total Debt Repaid | -0.03 | - | - | -1 | -0.01 | Upgrade
|
Net Debt Issued (Repaid) | -0.03 | - | - | -1 | 0.93 | Upgrade
|
Issuance of Common Stock | 0.09 | 0.04 | 0.25 | 4.18 | 0.64 | Upgrade
|
Other Financing Activities | - | - | - | -0.1 | -0.06 | Upgrade
|
Financing Cash Flow | 0.06 | 0.04 | 0.25 | 3.08 | 1.51 | Upgrade
|
Foreign Exchange Rate Adjustments | -0 | - | - | - | - | Upgrade
|
Net Cash Flow | 0.86 | -0.34 | -1.39 | 1.71 | 0.29 | Upgrade
|
Free Cash Flow | 0.82 | -0.36 | -1.63 | -1.34 | -1.22 | Upgrade
|
Free Cash Flow Margin | 17.21% | -10.36% | -92.24% | -1090.74% | -3703.89% | Upgrade
|
Free Cash Flow Per Share | 0.01 | -0.00 | -0.02 | -0.01 | -0.02 | Upgrade
|
Levered Free Cash Flow | 0.79 | -0.05 | -1.23 | -0.65 | -1.06 | Upgrade
|
Unlevered Free Cash Flow | 0.79 | -0.05 | -1.23 | -0.63 | -0.97 | Upgrade
|
Change in Net Working Capital | 0.11 | -0.24 | 0.13 | 0.12 | 0.44 | Upgrade
|
Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.